Related Experiment Video

Updated: Apr 25, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.2K

MicroRNA-29a is a friend or foe for cardiac hypertrophy?

Hui Tao, Jing-Jing Yang, Jun Li

    Journal of the American College of Cardiology
    |August 23, 2014
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization08:22

    Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

    Published on: September 15, 2018

    7.5K
    Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

    Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

    Published on: August 3, 2018

    10.1K

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    801